Study of the relationship between the level of pro-inflammatory cytokines and β2-microglobulin with indicators of changes in the functional status of the kidneys in diabetic nepropathy to determine the degrees of chronic renal failure
1
Department of Physiology, Kharkiv National Medical University, Ukraine
2
Department of Pathological Anatomy, Kharkiv National Medical University, Ukraine
3
Department of Medical and Biological Physics and Medical Informatics, Kharkiv National Medical University, Ukraine
4
Department of Hygiene and Ecology №2, Kharkiv National Medical University, Ukraine
5
Department of Clinical Laboratory Diagnostics, Kharkiv National Medical University, Ukraine
Submission date: 2024-07-02
Final revision date: 2024-08-12
Acceptance date: 2024-12-09
Publication date: 2025-02-28
Corresponding author
Liubov Rysovana
Department of Medical and Biological Physics and Medical Informatics, Kharkiv National Medical University, Ukraine
Department of Medical and Biological Physics and Medical Informatics, Kharkiv National Medical University, Ukraine
Wiadomości Lekarskie 2025;(2):248-256
KEYWORDS
TOPICS
ABSTRACT
Aim:
The purpose of this study is to analyze the correlations of pro-inflammatory cytokines and β2-microglobulin with indicators of changes in the functional state of kidneys in patients with diabetic nephropathy, to determine different degrees of chronic renal failure.
Material and methods:
80 patients with type 1 and type 2 diabetes, complicated by diabetic nephropathy, at different levels of the functional state of the kidneys were examined.
Results:
It has been shown that the level of tumor necrosis factor α (TNFα) in the blood of patients with diabetic nephropathy (DN) is increased already with sufficient kidney function, decreases with chronic renal failure (CRF) of the I degree and reaches maximum values with CRF of the II and III degrees. which indicates the degree of progression of fibroplastic and sclerotic processes in the kidneys with DN. The level of interleukin-1α (IL-1α) in the blood of patients with DN begins to decrease with sufficient kidney function, increases with CRF of the II degree, but remains below the values of the control group and is minimal in patients with CRF of the III degree, which reflects a decrease in the intensity of the acute-phase inflammatory process in the development of CRF.
Conclusions:
The development and progression of CRF is accompanied by an increase in the excretion of β2-microglobulin in the urine in parallel with changes in the cytokine profile in the blood.
The purpose of this study is to analyze the correlations of pro-inflammatory cytokines and β2-microglobulin with indicators of changes in the functional state of kidneys in patients with diabetic nephropathy, to determine different degrees of chronic renal failure.
Material and methods:
80 patients with type 1 and type 2 diabetes, complicated by diabetic nephropathy, at different levels of the functional state of the kidneys were examined.
Results:
It has been shown that the level of tumor necrosis factor α (TNFα) in the blood of patients with diabetic nephropathy (DN) is increased already with sufficient kidney function, decreases with chronic renal failure (CRF) of the I degree and reaches maximum values with CRF of the II and III degrees. which indicates the degree of progression of fibroplastic and sclerotic processes in the kidneys with DN. The level of interleukin-1α (IL-1α) in the blood of patients with DN begins to decrease with sufficient kidney function, increases with CRF of the II degree, but remains below the values of the control group and is minimal in patients with CRF of the III degree, which reflects a decrease in the intensity of the acute-phase inflammatory process in the development of CRF.
Conclusions:
The development and progression of CRF is accompanied by an increase in the excretion of β2-microglobulin in the urine in parallel with changes in the cytokine profile in the blood.
REFERENCES (17)
1.
Yee H Wong, Shen H Wong, Xiao T Wong et al. (2021) Genetic associated complications of type 2 diabetes mellitus. Panminerva Med, Jun;64(2):274-288. DOI: 10.23736/S0031-0808.21.04285-3.
2.
Wang Z., Gong Y., Fan F. et al. (2020) Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis. Renal Failure, 42(1): 107-112. DOI: 10.1080/0886022X.2019.1710187.
3.
Rofyda H Aly, Amr E Ahmed, Walaa G Hozayen (2020) Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients. Front Physiol; 23:11:609223. DOI: 10.3389/fphys.2020.609223.
4.
Badr R. E., Salama M. I., Abd-Elmaogood A. K., Eldeib A. E. M. (2019). Toll-like receptor 2 expression on monocytes and microvascular complications in type 2 diabetic patients. Diabetes Metab. Syndr. 13, 1299–1302. DOI: 10.1016/j.dsx.2019.01.038.
5.
Rysz J, Gluba-Brzózka A, Franczyk B et al. (2017) Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome. Int. J. Molecular Sciences; 18:1702. DOI: 10.3390/ijms18081702.
6.
Ruiz-Ortega M., Rodrigues-Diez R., Lavoz C. et al. (2020). Special Issue Diabetic Nephropathy: Diagnosis, Prevention and Treatment”. J Clinical Medicine; 9:813. DOI: 10.3390/jcm9030813“.
7.
Azim Sharaf UA, Mansour MS, Abdulazim DO. (2017) Recent Advances in Management of Diabetic Nephropathy. Journal of Clinical & Experimental Nephrology; 2:35 DOI: 10.21767/2472-5056.100035.
8.
Wang J, Feng Y, Zhang Y et al. (2022) TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters. J Inflamm Res; 15:6657-6673. DOI: 10.2147/JIR.S391473..
9.
Maha Maqsood, Saima Sharif, Shagufta Naz et al. (2023) Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population Mol Biol;50(4):3249-3257. DOI: 10.1007/s11033-023-08249-z.
10.
Oguntibeju O.O. (2019) Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. J Physiology, Pathophysiology, Pharmacology; 11(3):45–63. PMCID: PMC6628012.
11.
Zheng S, Wang H, Han J et al. (2023) Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport. iScience; 26(11):108092. DOI: 10.1016/j.isci.2023.108092.
12.
Chakraborty R., Parveen R., Varshney P. et al. (2021) Elevated urinary IL-36α and IL-18 levels are associated with diabetic nephropathy in patients with type 2 diabetes mellitus. Minerva Endocrinol (Torino); 46(2):226-232. DOI: 10.23736/S2724-6507.20.03196-X.
13.
Mahaboob K.S. (2019) Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management. Diabetology & Metabolic Syndrome; 11:137-144. DOI: 10.1186/s13098-019-0403-4.
14.
Zhang J, Liu J, Qin X. (2018) Advances in early biomarkers of diabetic nephropathy. Rev Association Medicine Bras; 64(1):85–92. DOI: 10.1590/1806-9282.64.01.85.
15.
Magee C, Grieve D.J., Watson C.J., Brazil D.P. (2017) Diabetic nephropathy: a tangled web to unweave. Cardiovasc Drugs Ther; 31(5–6):579–592. DOI: 10.1007/s10557-017-6755-9.
16.
Yang B., Zhao X.H., Ma G. (2022) Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases; 10(23):8205-8211. DOI: 10.12998/wjcc.v10.i23.8205.
17.
Uemura T., Nishimoto M., Eriguchi M. et al. (2024) Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy. Diabetes Obes Metab; 26(2):583-591. DOI: 10.1111/dom.15347.
| eISSN: | 2719-342X |
| ISSN: | 0043-5147 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
